Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924560 · ClinicalTrials.gov registry record · Phase 2
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,361
- Enrollment target
NCT00924560 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 1,361 participants.
The verdict
NCT00924560, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,361 participants
- Enrollment target
Study Summary
This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.
Interventions
- DRUG 91-day Levonorgestrel Oral Contraceptive
- DRUG 28-day Levonorgestrel Oral Contraceptive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,361 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00924560
The ClinicalTrials.gov registry entry for NCT00924560 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 91-day Levonorgestrel Oral Contraceptive is the first listed.
NCT00924560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00924560 about?
NCT00924560 is a clinical study titled "A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females". This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.
What is the current status of trial NCT00924560?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,361 participants. The study started on 2009-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00924560?
The interventions under investigation include: 91-day Levonorgestrel Oral Contraceptive (DRUG), 28-day Levonorgestrel Oral Contraceptive (DRUG).
Who is sponsoring clinical trial NCT00924560?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.